HCA HEALTHCARE INC (HCA) Stock Fundamental Analysis

NYSE:HCA • US40412C1018

530.165 USD
+0.46 (+0.09%)
Last: Mar 2, 2026, 02:12 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Overall HCA gets a fundamental rating of 5 out of 10. We evaluated HCA against 101 industry peers in the Health Care Providers & Services industry. While HCA has a great profitability rating, there are quite some concerns on its financial health. HCA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • HCA had positive earnings in the past year.
  • HCA had a positive operating cash flow in the past year.
  • HCA had positive earnings in each of the past 5 years.
  • Each year in the past 5 years HCA had a positive operating cash flow.
HCA Yearly Net Income VS EBIT VS OCF VS FCFHCA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • With an excellent Return On Assets value of 11.17%, HCA belongs to the best of the industry, outperforming 96.04% of the companies in the same industry.
  • HCA has a better Return On Invested Capital (21.20%) than 95.05% of its industry peers.
  • HCA had an Average Return On Invested Capital over the past 3 years of 19.10%. This is significantly above the industry average of 9.08%.
  • The 3 year average ROIC (19.10%) for HCA is below the current ROIC(21.20%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.17%
ROE N/A
ROIC 21.2%
ROA(3y)10.06%
ROA(5y)10.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)19.1%
ROIC(5y)18.5%
HCA Yearly ROA, ROE, ROICHCA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500

1.3 Margins

  • HCA's Profit Margin of 8.97% is amongst the best of the industry. HCA outperforms 93.07% of its industry peers.
  • HCA's Profit Margin has improved in the last couple of years.
  • With an excellent Operating Margin value of 15.83%, HCA belongs to the best of the industry, outperforming 94.06% of the companies in the same industry.
  • HCA's Operating Margin has improved in the last couple of years.
  • With an excellent Gross Margin value of 84.96%, HCA belongs to the best of the industry, outperforming 97.03% of the companies in the same industry.
  • In the last couple of years the Gross Margin of HCA has remained more or less at the same level.
Industry RankSector Rank
OM 15.83%
PM (TTM) 8.97%
GM 84.96%
OM growth 3Y1.74%
OM growth 5Y2.35%
PM growth 3Y-1.43%
PM growth 5Y4.26%
GM growth 3Y0.21%
GM growth 5Y0.29%
HCA Yearly Profit, Operating, Gross MarginsHCA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), HCA is creating value.
  • Compared to 1 year ago, HCA has less shares outstanding
  • HCA has less shares outstanding than it did 5 years ago.
  • HCA has a worse debt/assets ratio than last year.
HCA Yearly Shares OutstandingHCA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
HCA Yearly Total Debt VS Total AssetsHCA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • HCA has a debt to FCF ratio of 6.04. This is a slightly negative value and a sign of low solvency as HCA would need 6.04 years to pay back of all of its debts.
  • HCA has a Debt to FCF ratio of 6.04. This is comparable to the rest of the industry: HCA outperforms 57.43% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.04
Altman-Z N/A
ROIC/WACC2.72
WACC7.79%
HCA Yearly LT Debt VS Equity VS FCFHCA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B 30B 40B

2.3 Liquidity

  • A Current Ratio of 0.97 indicates that HCA may have some problems paying its short term obligations.
  • With a Current ratio value of 0.97, HCA is not doing good in the industry: 71.29% of the companies in the same industry are doing better.
  • HCA has a Quick Ratio of 0.97. This is a bad value and indicates that HCA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HCA has a worse Quick ratio (0.86) than 70.30% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.86
HCA Yearly Current Assets VS Current LiabilitesHCA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 28.30% over the past year.
  • The Earnings Per Share has been growing by 23.50% on average over the past years. This is a very strong growth
  • HCA shows a small growth in Revenue. In the last year, the Revenue has grown by 7.08%.
  • Measured over the past years, HCA shows a small growth in Revenue. The Revenue has been growing by 7.97% on average per year.
EPS 1Y (TTM)28.3%
EPS 3Y18.86%
EPS 5Y23.5%
EPS Q2Q%44.58%
Revenue 1Y (TTM)7.08%
Revenue growth 3Y7.87%
Revenue growth 5Y7.97%
Sales Q2Q%6.72%

3.2 Future

  • Based on estimates for the next years, HCA will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.36% on average per year.
  • HCA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.48% yearly.
EPS Next Y6.83%
EPS Next 2Y8.55%
EPS Next 3Y10.12%
EPS Next 5Y12.36%
Revenue Next Year3.85%
Revenue Next 2Y4.39%
Revenue Next 3Y4.8%
Revenue Next 5Y5.48%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HCA Yearly Revenue VS EstimatesHCA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B 100B
HCA Yearly EPS VS EstimatesHCA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20 40 60

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 18.68, the valuation of HCA can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of HCA indicates a somewhat cheap valuation: HCA is cheaper than 72.28% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.07, HCA is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 17.49, which indicates a rather expensive current valuation of HCA.
  • Based on the Price/Forward Earnings ratio, HCA is valued a bit cheaper than 69.31% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of HCA to the average of the S&P500 Index (28.05), we can say HCA is valued slightly cheaper.
Industry RankSector Rank
PE 18.68
Fwd PE 17.49
HCA Price Earnings VS Forward Price EarningsHCA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 72.28% of the companies in the same industry are more expensive than HCA, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, HCA is valued a bit cheaper than 76.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.73
EV/EBITDA 10.74
HCA Per share dataHCA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HCA does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of HCA may justify a higher PE ratio.
PEG (NY)2.74
PEG (5Y)0.8
EPS Next 2Y8.55%
EPS Next 3Y10.12%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • HCA has a yearly dividend return of 0.59%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.48, HCA pays a better dividend. On top of this HCA pays more dividend than 82.18% of the companies listed in the same industry.
  • With a Dividend Yield of 0.59, HCA pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.59%

5.2 History

  • On average, the dividend of HCA grows each year by 44.46%, which is quite nice.
  • HCA has paid a dividend for at least 10 years, which is a reliable track record.
  • HCA has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)44.46%
Div Incr Years4
Div Non Decr Years4
HCA Yearly Dividends per shareHCA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • 10.01% of the earnings are spent on dividend by HCA. This is a low number and sustainable payout ratio.
  • The dividend of HCA is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP10.01%
EPS Next 2Y8.55%
EPS Next 3Y10.12%
HCA Yearly Income VS Free CF VS DividendHCA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
HCA Dividend Payout.HCA Dividend Payout, showing the Payout Ratio.HCA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

HCA HEALTHCARE INC

NYSE:HCA (3/2/2026, 2:12:08 PM)

530.165

+0.46 (+0.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)01-27
Earnings (Next)04-23
Inst Owners61.87%
Inst Owner Change-1.32%
Ins Owners0.95%
Ins Owner Change-50.98%
Market Cap120.98B
Revenue(TTM)75.60B
Net Income(TTM)6.78B
Analysts74.84
Price Target546.1 (3.01%)
Short Float %2.64%
Short Ratio3.46
Dividend
Industry RankSector Rank
Dividend Yield 0.59%
Yearly Dividend2.84
Dividend Growth(5Y)44.46%
DP10.01%
Div Incr Years4
Div Non Decr Years4
Ex-Date03-17
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.3%
Min EPS beat(2)8.05%
Max EPS beat(2)20.55%
EPS beat(4)4
Avg EPS beat(4)11.83%
Min EPS beat(4)8.05%
Max EPS beat(4)20.55%
EPS beat(8)6
Avg EPS beat(8)8.6%
EPS beat(12)9
Avg EPS beat(12)8.06%
EPS beat(16)11
Avg EPS beat(16)6.36%
Revenue beat(2)1
Avg Revenue beat(2)0.18%
Min Revenue beat(2)-1.84%
Max Revenue beat(2)2.2%
Revenue beat(4)1
Avg Revenue beat(4)-0.16%
Min Revenue beat(4)-1.84%
Max Revenue beat(4)2.2%
Revenue beat(8)3
Avg Revenue beat(8)0.16%
Revenue beat(12)7
Avg Revenue beat(12)0.68%
Revenue beat(16)8
Avg Revenue beat(16)0.33%
PT rev (1m)10.98%
PT rev (3m)11.84%
EPS NQ rev (1m)0.92%
EPS NQ rev (3m)0.8%
EPS NY rev (1m)1.48%
EPS NY rev (3m)0.97%
Revenue NQ rev (1m)-0.31%
Revenue NQ rev (3m)-0.54%
Revenue NY rev (1m)-0.52%
Revenue NY rev (3m)-0.7%
Valuation
Industry RankSector Rank
PE 18.68
Fwd PE 17.49
P/S 1.6
P/FCF 15.73
P/OCF 9.57
P/B N/A
P/tB N/A
EV/EBITDA 10.74
EPS(TTM)28.38
EY5.35%
EPS(NY)30.32
Fwd EY5.72%
FCF(TTM)33.71
FCFY6.36%
OCF(TTM)55.37
OCFY10.44%
SpS331.3
BVpS-26.41
TBVpS-71.52
PEG (NY)2.74
PEG (5Y)0.8
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 11.17%
ROE N/A
ROCE 26.97%
ROIC 21.2%
ROICexc 21.71%
ROICexgc 28.48%
OM 15.83%
PM (TTM) 8.97%
GM 84.96%
FCFM 10.17%
ROA(3y)10.06%
ROA(5y)10.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)19.1%
ROIC(5y)18.5%
ROICexc(3y)19.68%
ROICexc(5y)19.06%
ROICexgc(3y)25.77%
ROICexgc(5y)29.22%
ROCE(3y)24.29%
ROCE(5y)23.53%
ROICexgc growth 3Y-3.7%
ROICexgc growth 5Y-0.21%
ROICexc growth 3Y8.29%
ROICexc growth 5Y7.06%
OM growth 3Y1.74%
OM growth 5Y2.35%
PM growth 3Y-1.43%
PM growth 5Y4.26%
GM growth 3Y0.21%
GM growth 5Y0.29%
F-Score7
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.04
Debt/EBITDA 2.69
Cap/Depr 140.34%
Cap/Sales 6.54%
Interest Coverage 5.42
Cash Conversion 81.59%
Profit Quality 113.38%
Current Ratio 0.97
Quick Ratio 0.86
Altman-Z N/A
F-Score7
WACC7.79%
ROIC/WACC2.72
Cap/Depr(3y)147.23%
Cap/Depr(5y)143.02%
Cap/Sales(3y)6.92%
Cap/Sales(5y)6.83%
Profit Quality(3y)100.23%
Profit Quality(5y)90.24%
High Growth Momentum
Growth
EPS 1Y (TTM)28.3%
EPS 3Y18.86%
EPS 5Y23.5%
EPS Q2Q%44.58%
EPS Next Y6.83%
EPS Next 2Y8.55%
EPS Next 3Y10.12%
EPS Next 5Y12.36%
Revenue 1Y (TTM)7.08%
Revenue growth 3Y7.87%
Revenue growth 5Y7.97%
Sales Q2Q%6.72%
Revenue Next Year3.85%
Revenue Next 2Y4.39%
Revenue Next 3Y4.8%
Revenue Next 5Y5.48%
EBIT growth 1Y13.44%
EBIT growth 3Y9.74%
EBIT growth 5Y10.5%
EBIT Next Year33.96%
EBIT Next 3Y13.98%
EBIT Next 5Y10.71%
FCF growth 1Y36.41%
FCF growth 3Y23.07%
FCF growth 5Y3.76%
OCF growth 1Y20.18%
OCF growth 3Y14.03%
OCF growth 5Y6.48%

HCA HEALTHCARE INC / HCA FAQ

What is the fundamental rating for HCA stock?

ChartMill assigns a fundamental rating of 5 / 10 to HCA.


What is the valuation status of HCA HEALTHCARE INC (HCA) stock?

ChartMill assigns a valuation rating of 5 / 10 to HCA HEALTHCARE INC (HCA). This can be considered as Fairly Valued.


What is the profitability of HCA stock?

HCA HEALTHCARE INC (HCA) has a profitability rating of 9 / 10.


What is the financial health of HCA HEALTHCARE INC (HCA) stock?

The financial health rating of HCA HEALTHCARE INC (HCA) is 2 / 10.


Can you provide the expected EPS growth for HCA stock?

The Earnings per Share (EPS) of HCA HEALTHCARE INC (HCA) is expected to grow by 6.83% in the next year.